The Investing Title

InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing…

Thermos recalls 8.2 million bottles after stoppers eject, causing injury and reported vision loss

Build-A-Bear recalls roughly 36,000 Heart-Warming Hugs Bears

DHS scorches Pritzker’s ‘sanctuary’ state after child rapist on ICE detainer released

DC police captain cites bodycam footage of officers not making arrests, sparking backlash

Socialist mayor’s blunt 1-word message to fleeing millionaires sparks outrage: ‘We’re doomed’

MN governor race to replace Walz sees major shakeup as GOP contender ends campaign: ‘Don’t see a path’

Investing

Business

Politics

Over 200 House Dems vote against criminalizing transgender surgery for kids

Investing

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

Stock

Categories

Latest

DAVID MARCUS: Trump’s aggression toward Venezuela a warning to Putin

Rosie O’Donnell’s Trump obsession continues unabated from Ireland as friends beg her to ‘disconnect’

Judge rules evidence linked to James Comey’s ally is off limits to DOJ

Kelsey Grammer calls Trump ‘one of the greatest presidents we’ve ever had’ at Kennedy Center Honors

Top 5 Canadian Mining Stocks This Week: Bayhorse Silver Runs With 73 Percent Gain

Editor’s Picks: Silver Price Smashes All-time High, Nearly Hits US$60

Thermos recalls 8.2 million bottles after stoppers eject, causing injury and reported vision loss

Build-A-Bear recalls roughly 36,000 Heart-Warming Hugs Bears

DHS scorches Pritzker’s ‘sanctuary’ state after child rapist on ICE detainer released